{"entity":{"type":"insider","cik":"0001867470","url":"/insider/0001867470","json_url":"/insider/0001867470.json","name":"Northpond Ventures GP, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":6,"first":"2021-06-24","last":"2024-10-17","span_basis":"filed_date"},"name_variants":[{"name":"Northpond Ventures GP, LLC","source":"filing","n_filings":6,"first_seen":"2021-06-24","last_seen":"2024-10-17"}],"transactions":[{"id":3087133,"accession":"0001415889-24-025393","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-025393","line_url":"/filing/0001415889-24-025393#line-3","is_derivative":false,"issuer_cik":"0001736730","issuer_name":"Camp4 Therapeutics Corp","issuer_ticker":"CAMP","issuer_name_source":null,"issuer_url":"/issuer/0001736730","owner_cik":null,"owner_name":"Northpond Ventures GP, LLC; Northpond Ventures, LP; Northpond Ventures II, LP; Northpond Ventures III, LP; Northpond Ventures III GP, LLC; Rubin Michael P.","owner_display_name":"Northpond Ventures GP, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":763636.0,"shares_display":"763,636","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":8399996.0,"total_display":"8,399,996.00","total_whole":"8,399,996","shares_owned_after":763636.0,"shares_owned_after_display":"763,636","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-15","filed_date":"2024-10-17","scope":"insider"},{"id":8062993,"accession":"0000899243-23-016413","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-016413","line_url":"/filing/0000899243-23-016413","is_derivative":false,"issuer_cik":"0001645569","issuer_name":"DICE Therapeutics, Inc.","issuer_ticker":"DICE","issuer_name_source":null,"issuer_url":"/issuer/0001645569","owner_cik":null,"owner_name":"Northpond Ventures GP II, LLC; Northpond Ventures, LP; Northpond Ventures GP, LLC; Rubin Michael P.; Northpond Ventures II, LP","owner_display_name":"Northpond Ventures GP II, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2492871.0,"shares_display":"2,492,871","price_per_share":46.5,"price_display":"46.50","price_state":"stated","total_value":115918501.5,"total_display":"115,918,501.50","total_whole":"115,918,502","shares_owned_after":633707.0,"shares_owned_after_display":"633,707","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-22","filed_date":"2023-06-23","scope":"insider","n_lines":2},{"id":6263180,"accession":"0000899243-22-001631","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-001631","line_url":"/filing/0000899243-22-001631#line-3","is_derivative":false,"issuer_cik":"0001827087","issuer_name":"Vigil Neuroscience, Inc.","issuer_ticker":"VIGL","issuer_name_source":null,"issuer_url":"/issuer/0001827087","owner_cik":null,"owner_name":"Northpond Ventures, LP; Rubin Michael P.; Northpond Ventures II, LP; Northpond Ventures GP, LLC; Northpond Ventures GP II, LLC","owner_display_name":"Northpond Ventures, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":355000.0,"shares_display":"355,000","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":4970000.0,"total_display":"4,970,000.00","total_whole":"4,970,000","shares_owned_after":1382978.0,"shares_owned_after_display":"1,382,978","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-11","filed_date":"2022-01-11","scope":"insider"},{"id":5500435,"accession":"0001209191-21-060463","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-060463","line_url":"/filing/0001209191-21-060463#line-3","is_derivative":false,"issuer_cik":"0001615055","issuer_name":"IsoPlexis Corp","issuer_ticker":"ISO","issuer_name_source":null,"issuer_url":"/issuer/0001615055","owner_cik":null,"owner_name":"Northpond Ventures GP, LLC; Northpond Capital, L.P.; Rubin Michael P.; Northpond Ventures, LP; Northpond Capital GP, LLC","owner_display_name":"Northpond Ventures GP, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000000.0,"shares_display":"1,000,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":15000000.0,"total_display":"15,000,000.00","total_whole":"15,000,000","shares_owned_after":2080961.0,"shares_owned_after_display":"2,080,961","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-12","filed_date":"2021-10-14","scope":"insider"},{"id":5038421,"accession":"0000899243-21-036646","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-036646","line_url":"/filing/0000899243-21-036646#line-3","is_derivative":false,"issuer_cik":"0001645569","issuer_name":"DICE Therapeutics, Inc.","issuer_ticker":"DICE","issuer_name_source":null,"issuer_url":"/issuer/0001645569","owner_cik":null,"owner_name":"Northpond Ventures II, LP; Northpond Ventures GP, LLC; Northpond Ventures GP II, LLC; Northpond Ventures, LP; Rubin Michael P.","owner_display_name":"Northpond Ventures II, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":235000.0,"shares_display":"235,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":3995000.0,"total_display":"3,995,000.00","total_whole":"3,995,000","shares_owned_after":3292871.0,"shares_owned_after_display":"3,292,871","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-17","filed_date":"2021-09-20","scope":"insider"},{"id":5364100,"accession":"0000899243-21-025745","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-025745","line_url":"/filing/0000899243-21-025745#line-2","is_derivative":false,"issuer_cik":"0001850079","issuer_name":"Codex DNA, Inc.","issuer_ticker":"DNAY","issuer_name_source":null,"issuer_url":"/issuer/0001850079","owner_cik":null,"owner_name":"Northpond Ventures II, LP; Northpond Ventures GP II, LLC; Rubin Michael P.; Northpond Ventures, LP; Northpond Ventures GP, LLC","owner_display_name":"Northpond Ventures II, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":468750.0,"shares_display":"468,750","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":7500000.0,"total_display":"7,500,000.00","total_whole":"7,500,000","shares_owned_after":9844130.0,"shares_owned_after_display":"9,844,130","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-22","filed_date":"2021-06-24","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001736730","name":"Camp4 Therapeutics Corp","url":"/issuer/0001736730","role":"Ten percent owner","n_filings":1,"first_seen":"2024-10-17","last_seen":"2024-10-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001645569","name":"DICE Therapeutics, Inc.","url":"/issuer/0001645569","role":"Ten percent owner","n_filings":2,"first_seen":"2021-09-20","last_seen":"2023-06-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001827087","name":"Vigil Neuroscience, Inc.","url":"/issuer/0001827087","role":"Ten percent owner","n_filings":1,"first_seen":"2022-01-11","last_seen":"2022-01-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001615055","name":"IsoPlexis Corp","url":"/issuer/0001615055","role":"Ten percent owner","n_filings":1,"first_seen":"2021-10-14","last_seen":"2021-10-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001850079","name":"Codex DNA, Inc.","url":"/issuer/0001850079","role":"Ten percent owner","n_filings":1,"first_seen":"2021-06-24","last_seen":"2021-06-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001867470","retrieved_at":"2026-08-23T21:07:43+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}